When Joseph Lubega, M.D., returned to Uganda in 2016 to care for children with cancer, the grim reality was that up to 90 percent of them would not survive. Inadequate health care and a severe lack of specialists meant that proper diagnosis, treatment and care were simply out of reach.
Three innovators working to change cancer care awarded a combined $100,000 in grants following live pitch to a panel of judges that included celebrity entrepreneur Bill Rancic.
Winning idea aims to change the way Nigerians learn and talk about breast cancer
Press Release
Three innovators working to change cancer care awarded a combined $100,000 in grants following live pitch to a panel of judges that included celebrity entrepreneur Bill Rancic.
Winning idea aims to change the way Nigerians learn and talk about breast cancer
Bill and Giuliana Rancic to Lend Expertise, Passion and Personal Cancer Experience to Inspire Fellow Entrepreneurs C3 Prize Category Winners will compete for the Grand Prize during a live event at the Union for International Cancer Control (UICC) World Cancer Control (UICC) World Cancer Congress on October 3 in Kuala Lumpur, Malaysia.
Press Release
Bill and Giuliana Rancic to Lend Expertise, Passion and Personal Cancer Experience to Inspire Fellow Entrepreneurs C3 Prize Category Winners will compete for the Grand Prize during a live event at the Union for International Cancer Control (UICC) World Cancer Control (UICC) World Cancer Congress on October 3 in Kuala Lumpur, Malaysia.
2018 Challenge Will Award a Total of $100,000 in New Grants to Help Reduce the Unequal Burden of Cancer - All Healthcare Innovators Encouraged to Apply
Press Release
TOKYO, June 1, 2018 /3BL Media/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") have announced the launch of the third annual Astellas Oncology C3 Prize (Changing Cancer Care), a global challenge aimed at inspiring non-treatment ideas that may improve cancer care for patients and their loved ones. This year's challenge will focus on solutions for cancer care in low- and middle-income countries, which bear a disproportionate burden of the global cancer epidemic.1,2,3
Pfizer’s advances in oncology demonstrate the Power of Scientific innovation to help improve lives, particularly the power of Immuno-oncology (I-O). Immuno-oncology uses the natural ability of the body’s immune system to recognize and fight tumors. This past year, Pfizer continued to advance its work in I-O because we recognize the urgency of finding anti-cancer alternatives to help patients who need them.
A Kentucky physician wages his own battle against lung cancer, one house call at a time
Article
Dr. Tony Weaver pulls out of the parking lot at St. Claire Regional Medical Center, a rural hospital in the small town of Morehead, Kentucky. He has a house call to make. Today’s appointment is 20 minutes from town, down a two-lane road with no cellphone reception.
He makes rounds of home visits every other week, seeing six or seven patients each time—a welcome change from the dozens he once rushed through on an average day at a clinic.
From April 5-8, Sanofi will participate in the 12th Continental Congress of the International Society of Pediatric Oncology (SIOP), organized this year on the African continent, in Morocco.
This meeting represents an important opportunity for health professionals and companies to meet and exchange on the issue of access to care in Africa.
By Chris Boerner, President and Head of U.S. Commercial
Blog
Over the past four decades, we have seen an unprecedented increase in cancer care innovation.
While only half of diagnosed cancer patients survived beyond five years in the 1970s, more than two-thirds do today. As a result, there are now a record 14 million cancer survivors in the United States.
Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy
Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi
Press Release
Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy
Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi
